The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database
Our study has confirmed certain known adverse effects and identified other potential hazards by providing preliminary safety data on the practical use of ranolazine. The results present vital safety information for physicians prescribing ranolazine. Notably, this study only identifies safety signals and does not establish causal relationships between ranolazine and the observed adverse events.
Authors
- Xiang Liu (ORCID: https://orcid.org/0000-0001-6888-4525)
- Tingting Zhang (ORCID: https://orcid.org/0000-0002-6575-6250)
- Zujun Wen
- Yan Yi (ORCID: https://orcid.org/0000-0003-2639-8574)
- Peng Liu (ORCID: https://orcid.org/0009-0007-5718-3206)
- Guoshun Lin
Institutions
- Fourth People's Hospital of Taiyuan (CN)
- Dazhou Central Hospital (CN)
- Chongqing Medical and Pharmaceutical College (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.3389/fphar.2025.1702875
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31